| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $215.4M | — | +16.6% |
| Cost of Revenue | $44.5M | — | +39.1% |
| Gross Profit | $170.9M | — | +11.9% |
| R&D Expense | $69.4M | — | +100.9% |
| SG&A Expense | $32.5M | — | +4.0% |
| Operating Income | $37.3M | — | -33.7% |
| Interest Expense | $3.2M | — | -15.7% |
| Pre-tax Income | $39.7M | — | -30.6% |
| Income Tax | $7.2M | — | -38.0% |
| Net Income | $32.5M | — | -28.7% |
| EPS (Basic) | $0.56 | — | -29.1% |
| EPS (Diluted) | $0.55 | — | -29.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $589.4M | -21.7% | +20.5% |
| Short-term Investments | $51.5M | +125.6% | +186.9% |
| Accounts Receivable | $108.2M | +11.8% | +2.1% |
| Inventory | $5.3M | -1.4% | -17.3% |
| Current Assets | $778.8M | -14.1% | +21.2% |
| Total Assets | $1.27B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $27.8M | — | -18.3% |
| Capital Expenditures | $128K | — | +0.0% |
| Investing Cash Flow | -$183.6M | — | -7875.0% |
| Financing Cash Flow | -$7.2M | — | -1950.6% |
| Free Cash Flow | $27.6M | — | -18.4% |
| +20.5% |
| Current Liabilities | $217.3M | -13.8% | +24.1% |
| Long-term Debt | $158.8M | -3.0% | -9.6% |
| Total Liabilities | $361.5M | -9.9% | +7.9% |
| Stockholders' Equity | $910.3M | +4.6% | +26.3% |